GSK-3β Inhibitor XVIII

Motesanib(453562-69-1)¹HNMR Motesanib(453562-69-1)¹HNMR 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID(56305-04-5)IR2 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID(56305-04-5)¹³CNMR 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID(56305-04-5)¹HNMR 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID(56305-04-5)MS 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID(56305-04-5)IR1 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone(371242-69-2)¹HNMR ERK Inhibitor(1049738-54-6)¹HNMR N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE(853625-60-2)¹HNMR JNJ-10198409(627518-40-5)¹HNMR Pictilisib(957054-30-7)¹HNMR MIF Antagonist, ISO-1(478336-92-4)¹HNMR NSC697923(343351-67-7)¹HNMR Trolox (53188-07-1)¹HNMR Glycogen Phosphorylase Inhibitor(648926-15-2)¹HNMR C2 CERAMIDE(3102-57-6)¹HNMR PD 173074(219580-11-7)¹HNMR

More Pack up